Principal Financial Group Inc Adverum Biotechnologies, Inc. Transaction History

Principal Financial Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.81 - $1.34 $9,004 - $14,896	-11,117 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$1.23 - $1.95 $769 - $1,220	-626 Reduced 5.33%	11,117 $15,000
Q4 2021 Feb 09, 2022	SELL	$1.74 - $2.4 $13,260 - $18,290	-7,621 Reduced 39.36%	11,743 $21,000
Q3 2021 Nov 09, 2021	SELL	$2.08 - $3.6 $27,381 - $47,390	-13,164 Reduced 40.47%	19,364 $42,000
Q2 2021 Aug 10, 2021	SELL	$3.36 - $10.56 $22,260 - $69,960	-6,625 Reduced 16.92%	32,528 $113,000
Q1 2021 May 10, 2021	SELL	$9.26 - $14.36 $5,981 - $9,276	-646 Reduced 1.62%	39,153 $386,000
Q4 2020 Feb 08, 2021	BUY	$9.84 - $14.26 $123,373 - $178,791	12,538 Added 45.99%	39,799 $431,000
Q3 2020 Nov 06, 2020	SELL	$10.3 - $21.64 $1,009 - $2,120	-98 Reduced 0.36%	27,261 $280,000
Q2 2020 Aug 05, 2020	BUY	$8.53 - $25.64 $147,364 - $442,956	17,276 Added 171.34%	27,359 $571,000
Q1 2020 May 12, 2020	BUY	$7.98 - $16.32 $80,462 - $164,554	10,083 New	10,083 $99,000
Q2 2019 Aug 12, 2019	SELL	$5.1 - $11.89 $112,322 - $261,865	-22,024 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$3.03 - $6.02 $675 - $1,342	223 Added 1.02%	22,024 $115,000
Q4 2018 Feb 14, 2019	SELL	$2.87 - $5.92 $55,468 - $114,415	-19,327 Reduced 46.99%	21,801 $69,000
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $3,451 - $5,829	767 Added 1.9%	41,128 $249,000
Q2 2018 Aug 13, 2018	BUY	$5.3 - $6.9 $213,913 - $278,490	40,361 New	40,361 $0

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.